Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

ESWT added to rehabilitation for CRPS-I after a distal radius fracture

Official title: EXTRACORPOREAL SHOCKWAVE THERAPY FOR COMPLEX REGIONAL PAIN SYNDROME TYPE I FOLLOWING DISTAL RADIUS FRACTURE: A PROSPECTIVE RANDOMIZED SHAM-CONTROLLED TRIAL

Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07807852 · Data updated 2026-11-12

This trial tests whether adding extracorporeal shock wave therapy to standard rehab helps adults with CRPS-I after a distal radius fracture.

More Distal Radius Fracture trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorKanuni Sultan Suleyman Training and Research Hospital
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedJune 26, 2026
Main results expectedJune 26, 2027
Study endsSeptember 26, 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT07807852 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with CRPS-I following distal radius fracture, meeting Budapest criteria, and able to participate in assessments.

Probably not a fit

Individuals whose CRPS-I does not respond to ESWT or who have contraindications to ESWT may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized, assessor-blinded trial compares active ESWT plus standard rehabilitation to sham ESWT plus standard rehabilitation in 60 adults with CRPS-I following distal radius fracture. Participants receive five weekly ESWT sessions targeting the forearm and wrist, with outcomes assessed at baseline, after week 5, and at week 12. The primary outcome is change in pain on the Visual Analog Scale, with secondary measures of upper-extremity function and other functional or clinical assessments. The study aims to determine if ESWT provides additional pain relief and functional benefits beyond conventional rehabilitation. Participants are adults aged 18 to 75 meeting Budapest criteria for CRPS-I and are randomized 1:1 to active or sham ESWT.

Why it matters

Potential benefit: If successful, adding ESWT could provide greater pain relief and improved function for people with CRPS-I after a distal radius fracture.

How similar studies have gone: Prior research in CRPS and ESWT has shown mixed results; this study adds rigorous sham-controlled data for this specific post-fracture CRPS-I population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

ge between 18 and 75 years Diagnosis of Complex Regional Pain Syndrome Type I (CRPS-I), stage 1-2, following distal radius fracture Meeting the Budapest clinical diagnostic criteria for CRPS-I Symptom duration between 1 and 6 months Visual Analog Scale (VAS) pain score ≥4 Ability to participate in study assessments, with or without an assistive device Adequate cognitive capacity to understand the study procedures Willingness to participate in the study and provide written informed consent

Exclusion Criteria:

Diagnosis of Complex Regional Pain Syndrome Type II (CRPS-II) Concomitant peripheral nerve injury in the upper extremity Active infection, malignancy, or open wound Severe skin lesion or impaired skin integrity in the treatment area Bleeding diathesis or severe coagulation disorder Anticoagulant treatment that constitutes a contraindication to ESWT Pregnancy or breastfeeding ESWT applied to the relevant region within the previous 3 months Inability to comply with assessments or study procedures due to severe psychiatric disease or cognitive impairment Inability to attend the study regularly Any condition considered by the investigator to make participation inappropriate

\-

Where it's running

  • Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.